Atlas Trials

TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer

Clinical trial NCT03192462 · COMPLETED

Trial details

NCT number
NCT03192462
Sponsor
Baylor College of Medicine
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2018-01-18
Primary completion
2020-06-15
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.